Clinical trial
Prevalence of Alpha-1 Antitrypsin Deficiency in a Cohort of Hepatocellular Carcinoma on Non-Cirrhotic Liver Without Identified Etiologies
NCT07145385 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Alpha-1 Antitrypsin Deficiency in a Cohort of Hepatocellular Carcinoma on Non-Cirrhotic Liver Without Identified Etiologies
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- September 30, 2027
- Enrollment
- 71 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
retrospective cohort of patients diagnosed with hcc on non-cirrhotic liver